Business Segment Information (Tables)

9 Months Ended

Jul. 31, 2025

Segment Reporting [Abstract]

Schedule of Segment Information

Segment information:

Periods Ended July 31,	Three Months				Nine Months
(In millions)	2025		2024		2025		2024
CooperVision net sales by category:
Toric and multifocal	$	358.8	$	326.4	$	1,006.6	$	934.0
Sphere, other	359.6		349.2		1,027.5		999.0
Total CooperVision net sales	$	718.4	$	675.6	$	2,034.1	$	1,933.0
CooperSurgical net sales by category:
Office and surgical	$	204.8	$	197.9	$	609.5	$	571.9
Fertility	137.1		129.3		383.7		372.1
Total CooperSurgical net sales	341.9		327.2		993.2		944.0
Total net sales	$	1,060.3	$	1,002.8	$	3,027.3	$	2,877.0
Operating income (loss):
CooperVision	$	202.6	$	172.7	$	572.9	$	487.7
CooperSurgical	(4.2)		41.3		39.7		86.9
Corporate	(22.7)		(21.5)		(70.1)		(67.3)
Total operating income	175.7		192.5		542.5		507.3
Interest expense	25.4		28.5		75.6		87.3
Other (income) expense, net	(1.6)		0.3		17.2		6.3
Income before income taxes	$	151.9	$	163.7	$	449.7	$	413.7

Schedule of Identifiable Assets by Segment

(In millions)	July 31, 2025		October 31, 2024
Total identifiable assets:
CooperVision	$	7,511.7	$	7,285.1
CooperSurgical	4,671.0		4,832.0
Corporate	194.0		198.1
Total	$	12,376.7	$	12,315.2

Schedule of Net Sales to Unaffiliated Customers by Country of Domicile

Geographic information:

Periods Ended July 31,	Three Months				Nine Months
(In millions)	2025		2024		2025		2024
Net sales to unaffiliated customers by country of domicile:
United States	$	516.2	$	511.2	$	1,527.8	$	1,460.6
Europe	343.1		297.0		922.5		850.3
Rest of world	201.0		194.6		577.0		566.1
Total	$	1,060.3	$	1,002.8	$	3,027.3	$	2,877.0

Schedule of Net Property, Plant and Equipment by Country of Domicile

(In millions)	July 31, 2025		October 31, 2024
Net property, plant and equipment by country of domicile:
United States	$	1,301.5	$	1,188.8
Europe	423.3		401.7
Rest of world	263.9		272.9
Total	$	1,988.7	$	1,863.4